ONCOLife Articles
30 January 2025
How AI Could Overcome Data Scarcity to Transform Medicine
10 January 2025
The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia
FDA & EMA
27 November 2024
SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer
Clinical Trials
26 November 2024
FDA Greenlights Revumenib for Relapsed Leukemia Treatment
ONCOLife
23 November 2024
FDA Approves Ziihera as First Dual HER2-Targeted Therapy for Biliary Tract Cancer
ONCOLife
22 November 2024
How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment
ONCOLife
20 November 2024
UK Researchers Launch Groundbreaking Study to Uncover Cancer Survival Secrets
ONCOLife
19 November 2024
FDA Approves MI Cancer Seek Test for Targeted Cancer Therapy
ONCOLife
9 November 2024
IMUNON’s Novel Immunotherapy IMNN-001 Enhances Survival in Ovarian Cancer
Clinical Trials
7 November 2024
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.